Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 415, 364 (24 January 2002) | doi:10.1038/415364b
nature jobs
Two Post-Doctoral Position In Nanomedicine
- Fondazione IRCCS Istituto Neurologico "Carlo Besta" (FINCB)
- Via Celoria n.11, 20133 Milano, Italy
International PhD Programme
- MRC Laboratory of Molecular Biology
- Cambridge, UK
Bioweapon agents: more access means more risk
Richard H. Ebright1 & Nancy D. Connell2
- Howard Hughes Medical Institute, Waksman Institute, Department of Chemistry, Rutgers University, Piscataway, New Jersey 08854, USA
- Center for Biodefense, Lourenco Center for the Study of Emerging and Re-emerging Pathogens, New Jersey Medical School, Department of Microbiology and Molecular Genetics, UMDNJ, Newark, New Jersey 07103, USA
In the News Review article "Bioweapons: Delivering death in the mail" (Nature 414, 837–838; 2001), you quote Stanford biophysicist Steven Block as opposing restrictions on access to bioweapons agents, endorsing having "a lot of terrific [biomedical] scientists working on the problem" and forecasting "a 'molecular arms race' between bioweapons developers and biodefence specialists".We believe that increasing the number of institutions and people with access to bioweapons agents will increase the likelihood of their release.
To read this story in full you will need to login or make a payment (see right).

